Regulating the immune system: The induction of regulatory T cells in the periphery

Arthritis Research and Therapy

Volumn 6, Issue 5, 2004, Pages 215-222

  Buckner, Jane H ^a   Ziegler, Steven F ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Interleukin 10; Regulatory T cell; Suppression; Tolerance; Transforming growth factor beta

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

CELL CONTACT; CELL DEATH; CELL POPULATION; CELL SELECTION; CLONAL ANERGY; CYTOKINE PRODUCTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INHIBITION KINETICS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; T-LYMPHOCYTES;

EID: 12344254024     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1226     Document Type: Review

References (75)

1. Sprent J, Kishimoto H: The thymus and negative selection. Immunol Rev 2002, 185:126-135.
2. Schwartz RH: T cell anergy. Annu Rev Immunol 2003, 21:305-334.
3. Groux H: An overview of regulatory T cells. Microbes Infect 2001, 3:883-889.
4. Cottrez F, Groux H: Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation 2004, 77:S12-S15.
5. Bluestone JA, Abbas AK: Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003, 3:253-257.
6. + regulatory T cells. Nat Immunol 2003, 4:330-336.
7. + T regulatory cells. Nat Immunol 2003, 4: 337-342.
8. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
9. Ramsdell F: Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 2003, 19:165-168.
10. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
11. Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455-458.
12. Weiner HL: Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 2001, 3:947-954.
13. Levings MK, Bacchetta. R, Schulz U, Roncarolo MG: The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002, 129: 63-276.
14. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM: Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991, 147:2155-2163.
15. Melamed D, Friedman A: Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993, 23:935-942.
16. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 1992, 89: 421-425.
17. Lucas PJ, Kim SJ, Melby SJ, Gress RE: Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med 2000, 191:1187-1196.
18. Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998, 16:137-161.
19. Moore KW, de Waal MR, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19: 683-765.
20. Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH: CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002, 99:2468-2476.
21. Koppelman B, Neefjes JJ, de Vries JE, de Waal MR: Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997, 7:861-871.
22. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
23. + T cells. J Exp Med 1996, 184:19-29.
24. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000, 192: 213-1222.
25. + regulatory T cells obtained from cutaneous dinitrochlorobenzene-induced delayed type hypersensitivity reactions. J Invest Dermatol 2001, 117: 18-325.
26. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000, 114:295-302.
27. Kitani A, Chua K, Nakamura K, Strober W: Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol 2000, 165:691-702.
28. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421: 388-392.
29. Holler E, Roncarolo MG, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, Knabe H, Kolb HJ, Andreesen R, Wilmanns W: Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000, 25:237-241.
30. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz: CG: Human allograft acceptance is associated with immune regulation. J Clin Invest 2000, 106: 45-155.
31. Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal MR, de Vries JE, Roncarolo MG: High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994, 179:493-502.
32. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2:725-731.
33. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002, 8:625-629.
34. Chen C, Lee WH, Yun P, Snow P, Liu CP: Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 2003, 171:733-744.
35. Wildbaum G, Netzer N, Karin N: Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest 2002, 110:701-710.
36. McGuirk P, Mills KH: Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002, 23:450-455.
37. Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW, Sher A: Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002, 196:505-515.
38. Morelli AE, Thomson AW: Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003, 196:125-146.
39. +. J Immunol 2001, 166: 042-7052.
40. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, MacPherson GG: A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000, 191:435-444.
41. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605-617.
42. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001, 182:18-32.
43. Sakaguchi S, Sakaguchi N: Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J Exp Med 1990, 172:537-545.
44. Mottet C, Uhlig HH, Powrie F: Cutting edge: cure of colitis by CD4(+)CD25(+) regulatory T cells. J Immunol 2003, 170:3939-3943.
45. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
46. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002, 169:4712-4716.
47. Seddon B, Mason D: Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 1999, 189: 877-882.
48. Green EA, Choi Y, Flavell RA: Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 2002, 16: 183-191.
49. + regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA 2002, 99: 5620-15625.
50. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001, 2:301-306.
51. Lyon MF, Peters J, Glenister PH, Ball S, Wright E: The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc Natl Acad Sci USA 1990, 87:2433-2437.
52. Godfrey VL, Rouse BT, Wilkinson JE: Transplantation of T cell-mediated, mouse. Am J Pathol 1994, 145:281-286.
53. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF: Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001, 276:37672-37679.
54. +CD25 high regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
55. Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001, 31:1122-1131.
56. + regulatory T cells. Eur J Immunol 2002, 32: 621-1630.
57. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI: Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001, 98: 736-2744.
58. +. J Clin Invest 2003, 112:1437-1443.
59. Wildin RS, Smyk-Pearson S, Filipovich AH: Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39: 537-545.
60. Stephens LA, Mottet C, Mason D, Powrie F: Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001, 31: 1247-1254.
61. + T cells in thymus, cord and adult blood. Immunology 2002, 106:190-199.
62. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001, 193:1285-1294.
63. Suto A, Nakajima H, Ikeda K, Kubo S, Nakayama T, Taniguchi M, Saito Y, Iwamoto I: CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood 2002, 99:555-560.
64. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001, 167:188-195.
65. Apostolou I, Von Boehmer H: In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004, 199: 401-1408.
66. Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002, 196: 37-246.
67. Grundstrom S, Cederbom L, Sundstedt A, Scheipers P, Ivars F: Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4(+)CD25(+) regulatory T cells in vivo. J Immunol 2003, 170:5008-5017.
68. Duthoit CT, Nguyen P, Geiger TL: Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4(+) T cells. J Immunol 2004, 172:2238-2246.
69. - precursors. J Immunol 2002, 169:4183-4189.
70. +. J Exp Med 2003, 198:1875-1886.
71. Verhasselt V, Vosters O, Beuneu C, Nicaise C, Stordeur P, Goldman M: Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur J Immunol 2004, 34:762-772.
72. + regulatory T cells. J Immunol 2002, 169:3710-3716.
73. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
74. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002, 196:255-260.
75. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004, 199:1285-1291.